Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu
Ra Medical Systems Stock Quote

Ra Medical Systems (NYSEMKT: RMED)

$0.59
(-1.4%)
-$0.01
Price as of May 15, 2024, 3:57 p.m. ET

Ra Medical Systems Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
RMED -49.95% -99.99% -84.20% -100%
S&P +26.85% +82.41% +12.77% +80%

Ra Medical Systems Company Info

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Fort Mill, SC.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.